Literature DB >> 20232515

An overview of APP processing enzymes and products.

Vivian W Chow1, Mark P Mattson, Philip C Wong, Marc Gleichmann.   

Abstract

The generation of amyloid beta-peptide (A beta) by enzymatic cleavages of the beta-amyloid precursor protein (APP) has been at the center of Alzheimer's disease (AD) research. While the basic process of beta- and gamma-secretase-mediated generation of A beta is text book knowledge, new aspects of A beta and other cleavage products have emerged in recent years. Also our understanding of the enzymes involved in APP proteolysis has increased dramatically. All of these discoveries contribute to a more complete understanding of APP processing and the physiologic and pathologic roles of its secreted and intracellular protein products. Understanding APP processing is important for any therapeutic strategy aimed at reducing A beta levels in AD. In this review, we provide a concise description of the current state of understanding the enzymes involved in APP processing, the cleavage products generated by different processing patterns, and the potential functions of those cleavage products.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232515      PMCID: PMC2889200          DOI: 10.1007/s12017-009-8104-z

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  114 in total

1.  A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis.

Authors:  Quan-Hong Ma; Toshitaka Futagawa; Wu-Lin Yang; Xiao-Dan Jiang; Li Zeng; Yasuo Takeda; Ru-Xiang Xu; Dominique Bagnard; Melitta Schachner; Andrew J Furley; Domna Karagogeos; Kazutada Watanabe; Gavin S Dawe; Zhi-Cheng Xiao
Journal:  Nat Cell Biol       Date:  2008-02-17       Impact factor: 28.824

2.  Kinetic properties of cathepsin D and BACE 1 indicate the need to search for additional beta-secretase candidate(s).

Authors:  Israel Schechter; Etty Ziv
Journal:  Biol Chem       Date:  2008-03       Impact factor: 3.915

3.  Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.

Authors:  Piotr Lewczuk; Johannes Kornhuber; Hugo Vanderstichele; Eugeen Vanmechelen; Hermann Esselmann; Mirko Bibl; Stefanie Wolf; Markus Otto; Udo Reulbach; Heike Kölsch; Frank Jessen; Johannes Schröder; Peter Schönknecht; Harald Hampel; Oliver Peters; Erik Weimer; Robert Perneczky; Holger Jahn; Christian Luckhaus; Ulrich Lamla; Tillmann Supprian; Juan Manuel Maler; Jens Wiltfang
Journal:  Neurobiol Aging       Date:  2007-01-19       Impact factor: 4.673

4.  Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice.

Authors:  A V Savonenko; T Melnikova; F M Laird; K-A Stewart; D L Price; P C Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-02       Impact factor: 11.205

5.  Beta-site amyloid precursor protein-cleaving enzyme-1 (BACE1)-mediated changes of endogenous amyloid beta in wild-type and transgenic mice in vivo.

Authors:  Chiho Hirata-Fukae; Elkhansa Hassan Sidahmed; Thomas P Gooskens; Paul S Aisen; Ilse Dewachter; Herman Devijver; Fred Van Leuven; Yasuji Matsuoka
Journal:  Neurosci Lett       Date:  2008-03-10       Impact factor: 3.046

6.  Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.

Authors:  A B Clement; R Hanstein; A Schröder; H Nagel; K Endres; F Fahrenholz; C Behl
Journal:  Neuroscience       Date:  2008-01-12       Impact factor: 3.590

7.  Neuronal hypertrophy in asymptomatic Alzheimer disease.

Authors:  Diego Iacono; Richard O'Brien; Susan M Resnick; Alan B Zonderman; Olga Pletnikova; Gay Rudow; Yang An; Mark J West; Barbara Crain; Juan C Troncoso
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

8.  Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein.

Authors:  Vivian Y H Hook; Mark Kindy; Gregory Hook
Journal:  J Biol Chem       Date:  2008-01-09       Impact factor: 5.157

9.  Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.

Authors:  Melanie Meyer-Luehmann; Tara L Spires-Jones; Claudia Prada; Monica Garcia-Alloza; Alix de Calignon; Anete Rozkalne; Jessica Koenigsknecht-Talboo; David M Holtzman; Brian J Bacskai; Bradley T Hyman
Journal:  Nature       Date:  2008-02-07       Impact factor: 49.962

10.  BACE1 gene deletion: impact on behavioral function in a model of Alzheimer's disease.

Authors:  Dione Kobayashi; Michelle Zeller; Tracy Cole; Manuel Buttini; Lisa McConlogue; Sukanto Sinha; Stephen Freedman; Richard G M Morris; Karen S Chen
Journal:  Neurobiol Aging       Date:  2007-02-28       Impact factor: 4.673

View more
  180 in total

Review 1.  Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease.

Authors:  Vivian Hook; Gregory Hook; Mark Kindy
Journal:  Biol Chem       Date:  2010-08       Impact factor: 3.915

2.  Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer's disease following gastric bypass surgery.

Authors:  Husam Ghanim; Scott V Monte; Chang Ling Sia; Sanaa Abuaysheh; Kelly Green; Joseph A Caruana; Paresh Dandona
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

Review 3.  The keystone of Alzheimer pathogenesis might be sought in Aβ physiology.

Authors:  D Puzzo; W Gulisano; O Arancio; A Palmeri
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

Review 4.  Nonhuman primate models of Alzheimer-like cerebral proteopathy.

Authors:  Eric Heuer; Rebecca F Rosen; Amarallys Cintron; Lary C Walker
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 5.  Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.

Authors:  Miguel Moutinho; Gary E Landreth
Journal:  J Lipid Res       Date:  2017-03-06       Impact factor: 5.922

6.  Occlusal disharmony increases amyloid-β in the rat hippocampus.

Authors:  D Ekuni; T Tomofuji; K Irie; T Azuma; Y Endo; K Kasuyama; M Morita
Journal:  Neuromolecular Med       Date:  2011-07-13       Impact factor: 3.843

Review 7.  Functional interplay between tetraspanins and proteases.

Authors:  María Yáñez-Mó; Maria Dolores Gutiérrez-López; Carlos Cabañas
Journal:  Cell Mol Life Sci       Date:  2011-06-18       Impact factor: 9.261

Review 8.  Axonal commissures in the central nervous system: how to cross the midline?

Authors:  Homaira Nawabi; Valérie Castellani
Journal:  Cell Mol Life Sci       Date:  2011-05-03       Impact factor: 9.261

9.  Dopamine promotes cathepsin B-mediated amyloid precursor protein degradation by reactive oxygen species-sensitive mechanism in neuronal cell.

Authors:  Sanju Kumari; Abhishek Mukherjee; Chinmay K Mukhopadhyay
Journal:  Mol Cell Biochem       Date:  2018-10-22       Impact factor: 3.396

10.  Early Manifestations of Brain Aging in Mice Due to Low Dietary Folate and Mild MTHFR Deficiency.

Authors:  Renata H Bahous; Marta Cosín-Tomás; Liyuan Deng; Daniel Leclerc; Olga Malysheva; Ming-Kai Ho; Mercè Pallàs; Perla Kaliman; Barry J Bedell; Marie A Caudill; Rima Rozen
Journal:  Mol Neurobiol       Date:  2018-10-04       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.